[go: up one dir, main page]

AU2002342770A1 - Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised - Google Patents

Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Info

Publication number
AU2002342770A1
AU2002342770A1 AU2002342770A AU2002342770A AU2002342770A1 AU 2002342770 A1 AU2002342770 A1 AU 2002342770A1 AU 2002342770 A AU2002342770 A AU 2002342770A AU 2002342770 A AU2002342770 A AU 2002342770A AU 2002342770 A1 AU2002342770 A1 AU 2002342770A1
Authority
AU
Australia
Prior art keywords
sterilised
liposomes
sterile
filtered
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002342770A
Inventor
Jorg Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Publication of AU2002342770A1 publication Critical patent/AU2002342770A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002342770A 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised Abandoned AU2002342770A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10148067.9 2001-09-28
DE10148067A DE10148067A1 (en) 2001-09-28 2001-09-28 Heat sterilizable alkyl phosphocholine liposomes
PCT/EP2002/010882 WO2003028736A2 (en) 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Publications (1)

Publication Number Publication Date
AU2002342770A1 true AU2002342770A1 (en) 2003-04-14

Family

ID=7700759

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002342770A Abandoned AU2002342770A1 (en) 2001-09-28 2002-09-27 Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised

Country Status (3)

Country Link
AU (1) AU2002342770A1 (en)
DE (1) DE10148067A1 (en)
WO (1) WO2003028736A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1476201T3 (en) 2002-02-19 2009-03-30 Resolution Chemicals Ltd Solvent-based sterilization of steroids
WO2006024675A1 (en) * 2004-09-03 2006-03-09 Forschungszentrum Karlsruhe Gmbh Use of alkylphospholipids for the treatment of solid tumours
EP1827379B8 (en) * 2004-10-19 2011-05-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Formulations containing alkylphosphocholines using novel negative charge carriers
CA2632449A1 (en) * 2005-12-19 2007-06-28 Aeterna Zentaris Gmbh Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
DE102009007853A1 (en) * 2009-02-06 2010-08-12 LMU Ludwig-Maximilians-Universität München Intraocular lenses treated with alkylphosphocholines for pharmacological after-stage prophylaxis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088046B1 (en) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipids in the aqueous phase
DE4132345A1 (en) * 1991-09-27 1993-04-01 Max Planck Gesellschaft ETHER LYSOLECITHINES AND ALKYLPHOSPHOCHOLINE IN LIPOSOMES
DE4408011C1 (en) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Liposomes for tumour therapy
DE10015814A1 (en) * 2000-03-30 2001-10-11 Max Planck Gesellschaft Medicines to stimulate leukopoiesis, treat tumors and protozoan diseases and process for its manufacture

Also Published As

Publication number Publication date
DE10148067A1 (en) 2003-04-17
WO2003028736A2 (en) 2003-04-10
WO2003028736A3 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB0018828D0 (en) Alkyl Amino Acid Derivatives useful as pharmaceutical agents
AU2001259389A1 (en) Math coprocessor
AU2002324990A1 (en) Three-dimensional electrophoretic displays
CZ20011229A3 (en) Ophthalmological preparations
AU2002347910A1 (en) Methods and compositions for targeting proteins across the blood brain barrier
AUPR392301A0 (en) Protein phosphatase inhibitors
AU1046802A (en) Polyarylcarboxamides useful as lipid lowering agents
AU2001259059A1 (en) Beta-glucans encapsulated in liposomes
GC0000312A (en) Biphenylcarboxamides useful as lipid lowering agents
AU2002214131A1 (en) Improved 3d display
AU2001283530A1 (en) Dual-domain lateral shearing interferometer
AU2002342770A1 (en) Pharmaceutical preparations comprising alkyl phosphocholine compounds in liposomes which may be sterile-filtered or heat-sterilised
AU2002212496A1 (en) 3d display
AU2001269888A1 (en) Protein phosphatases
AU2002240942A1 (en) Improved delivery of benefit agents
AU2001283012A1 (en) Protein phosphatases
AU2002361850A1 (en) Medicinal aerosol formulations comprising ion pair complexes
AU2001292301A1 (en) Novel drugs for liver diseases
AU2002211005A1 (en) Lipid peroxide-lowering compositions
AU2001257427A1 (en) Rna metabolism proteins
AU2001295991A1 (en) Compositions for improving lipids in blood
AU2001268153A1 (en) Processing of plasmid-containing fluids
AU2001284827A1 (en) Virtual showcases
AU2001292001A1 (en) Pharmaceutical oxan preparation
AU2002214332A1 (en) Ophthalmological preparations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase